DK1014943T3 - Medicinske aerosolformuleringer - Google Patents

Medicinske aerosolformuleringer

Info

Publication number
DK1014943T3
DK1014943T3 DK98900837T DK98900837T DK1014943T3 DK 1014943 T3 DK1014943 T3 DK 1014943T3 DK 98900837 T DK98900837 T DK 98900837T DK 98900837 T DK98900837 T DK 98900837T DK 1014943 T3 DK1014943 T3 DK 1014943T3
Authority
DK
Denmark
Prior art keywords
aerosol formulations
hydrofluoroalkanes
carbon dioxide
active compounds
pressure
Prior art date
Application number
DK98900837T
Other languages
English (en)
Inventor
Manfred Keller
Kurt Herzog
Original Assignee
Jago Res Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jago Res Ag filed Critical Jago Res Ag
Application granted granted Critical
Publication of DK1014943T3 publication Critical patent/DK1014943T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
DK98900837T 1997-02-05 1998-02-02 Medicinske aerosolformuleringer DK1014943T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH24897 1997-02-05
PCT/CH1998/000037 WO1998034595A1 (de) 1997-02-05 1998-02-02 Medizinische aerosolformulierungen

Publications (1)

Publication Number Publication Date
DK1014943T3 true DK1014943T3 (da) 2002-10-14

Family

ID=4182679

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98900837T DK1014943T3 (da) 1997-02-05 1998-02-02 Medicinske aerosolformuleringer

Country Status (14)

Country Link
US (1) US6461591B1 (da)
EP (1) EP1014943B1 (da)
JP (1) JP2001511160A (da)
AT (1) ATE219355T1 (da)
AU (1) AU718967B2 (da)
CA (1) CA2280099C (da)
DE (1) DE59804534D1 (da)
DK (1) DK1014943T3 (da)
ES (1) ES2178817T3 (da)
NO (1) NO993773L (da)
NZ (1) NZ337065A (da)
PT (1) PT1014943E (da)
WO (1) WO1998034595A1 (da)
ZA (1) ZA98937B (da)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
GB2326334A (en) † 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6200352B1 (en) 1997-08-27 2001-03-13 Micell Technologies, Inc. Dry cleaning methods and compositions
US6218353B1 (en) * 1997-08-27 2001-04-17 Micell Technologies, Inc. Solid particulate propellant systems and aerosol containers employing the same
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
DE59911149D1 (de) * 1998-07-24 2004-12-30 Jago Res Ag Muttenz Medizinische aerosolformulierungen
HU226164B1 (en) * 1998-11-13 2008-05-28 Jagotec Ag Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
GB9908921D0 (en) * 1999-04-19 1999-06-16 Britannia Pharmaceuticals Ltd Spray dispenser for opiod antagonists
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
EP1175204A4 (en) * 1999-05-04 2006-05-31 Aradigm Corp AEROSOL FORMULATION AND ARTICLES FOR INCREASING LIBIDO IN WOMEN BY MOMENTARY TESTOSTERONE ADMINISTRATION
US7258850B2 (en) 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
AU7026800A (en) * 1999-09-11 2001-04-17 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
GB9928578D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Pharmaceutical formulations
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
US6248136B1 (en) 2000-02-03 2001-06-19 Micell Technologies, Inc. Methods for carbon dioxide dry cleaning with integrated distribution
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
CA2411047C (en) 2000-05-22 2009-08-04 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
GB0100560D0 (en) * 2001-01-09 2001-02-21 Lamination Technologies Ltd Clothing
CN100496608C (zh) * 2001-03-30 2009-06-10 洁垢技术有限公司 药用气溶胶制剂
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US6759029B2 (en) * 2001-05-24 2004-07-06 Alexza Molecular Delivery Corporation Delivery of rizatriptan and zolmitriptan through an inhalation route
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1446102A1 (en) 2001-11-21 2004-08-18 Alexza Molecular Delivery Corporation Delivery of caffeine through an inhalation route
LT3494995T (lt) 2002-03-01 2020-04-10 Chiesi Farmaceutici S.P.A. Ypatingai smulki formoterolio kompozicija
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
AU2003280102B2 (en) * 2002-06-28 2007-01-25 Alkermes, Inc. Inhalable epinephrine
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
CA2507158A1 (en) * 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Treatment of headache with antipsychotics delivered by inhalation
EP1567164B1 (en) 2002-11-26 2009-01-14 Alexza Pharmaceuticals, Inc. Use of loxapine for the manufacture of a medicament for the treatment of pain
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2006509825A (ja) * 2002-12-13 2006-03-23 大塚製薬株式会社 経肺投与用インターフェロン−γ凍結乾燥組成物及びその吸入システム
GB0229714D0 (en) * 2002-12-20 2003-01-29 Glaxo Group Ltd Novel apparatus and method
DE10260882B4 (de) * 2002-12-24 2007-02-08 IG Sprühtechnik GmbH & Co. KG Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung
AU2003205499A1 (en) * 2003-02-28 2004-09-17 Anbics Patents-Licences Ag Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides
CA2526470A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050043343A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
US11324698B2 (en) 2003-08-28 2022-05-10 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
US8846079B1 (en) * 2004-12-01 2014-09-30 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
US20060115523A1 (en) * 2004-12-01 2006-06-01 Konduri Kameswari S Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal
WO2005032521A2 (en) * 2003-10-02 2005-04-14 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US20050238632A1 (en) * 2004-04-23 2005-10-27 Alburty David S Propellant formulations
US20050255048A1 (en) * 2004-05-15 2005-11-17 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006076222A2 (en) * 2005-01-10 2006-07-20 Glaxo Group Limited Pharmaceutical formulations
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
TR201807714T4 (tr) * 2006-02-10 2018-06-21 Pari Pharma Gmbh İnhalasyon tedavisine yönelik nebülize antibiyotikler.
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
CA2723470C (en) * 2007-05-07 2013-12-03 Hale Biopharma Ventures, Llc Nasal administration of benzodiazepines
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
CA2756690C (en) 2008-03-28 2016-08-16 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US20120082626A1 (en) * 2009-06-16 2012-04-05 Wen Tan Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
EP3415139B8 (en) 2011-06-14 2022-05-18 Neurelis, Inc. Administration of benzodiazepine
MY171271A (en) 2011-08-19 2019-10-07 Intech Biopharm Ltd Method for preparing metered dose sprayed inhaler for treating respiratory disease
WO2017004501A1 (en) 2015-07-02 2017-01-05 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery
CN108289843B (zh) 2015-12-04 2021-08-17 墨西哥氟石股份公司 药物组合物
GB201702407D0 (en) * 2017-02-14 2017-03-29 Norton (Waterford) Ltd Inhalers and related methods
US20180243257A1 (en) * 2017-02-27 2018-08-30 Gregory LEVITIN Combination of furosemide and steroids and uses therefor
US20200268706A1 (en) * 2017-02-27 2020-08-27 Gregory LEVITIN Combination of furosemide and steroids and application system therefor
GB2592376A (en) * 2020-02-25 2021-09-01 Aer Beatha Ltd Canister

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (da) 1956-03-21 1900-01-01
BE556587A (da) 1957-01-31 1957-04-11
US4139617A (en) 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
NL7708731A (nl) 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CA1075854A (en) * 1976-08-16 1980-04-22 Charles W. Simons Aerosol propellants for personal products
JPS61158919A (ja) * 1984-12-28 1986-07-18 Taisho Pharmaceut Co Ltd 水虫治療剤
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
ES2096653T3 (es) 1990-06-29 1997-03-16 Fisons Plc Composiciones de aerosol presurizado.
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES1018186Y (es) 1991-05-17 1992-08-16 Cano Rodriguez Andres Soporte para un iman terapeutico.
ATE137666T1 (de) 1991-12-31 1996-05-15 Hoechst Ag Medizinische aerosolformulierung
SE523661C2 (sv) * 1992-02-05 2004-05-04 American Pacific Corp Gas-vätskeblandning avsedd för användning som brandsläckningsmedel
WO1993017335A1 (en) 1992-02-24 1993-09-02 Triton Diagnostics, Inc. Bridge immunoassay
US5301664A (en) * 1992-03-06 1994-04-12 Sievers Robert E Methods and apparatus for drug delivery using supercritical solutions
GB9214765D0 (en) * 1992-07-11 1992-08-26 Smithkline Beecham Plc Pressurised aerosol formulation
WO1994003056A1 (en) * 1992-07-31 1994-02-17 Ian Alexander Edwin Maccormick Aerosol insecticide composition
EE9700138A (et) * 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid

Also Published As

Publication number Publication date
NO993773L (no) 1999-10-04
CA2280099C (en) 2005-12-27
CA2280099A1 (en) 1998-08-13
ES2178817T3 (es) 2003-01-01
EP1014943B1 (de) 2002-06-19
NZ337065A (en) 2001-02-23
US6461591B1 (en) 2002-10-08
AU718967B2 (en) 2000-05-04
NO993773D0 (no) 1999-08-04
ATE219355T1 (de) 2002-07-15
WO1998034595A1 (de) 1998-08-13
ZA98937B (en) 1998-08-06
EP1014943A1 (de) 2000-07-05
PT1014943E (pt) 2002-11-29
AU5649698A (en) 1998-08-26
JP2001511160A (ja) 2001-08-07
DE59804534D1 (de) 2002-07-25

Similar Documents

Publication Publication Date Title
DK1014943T3 (da) Medicinske aerosolformuleringer
NO20010391D0 (no) Medisinske aerosolformuleringer
RU2214230C2 (ru) Аэрозольный препарат, адаптированный для использования в герметизированном аэрозольном контейнере
AU7286601A (en) Novel aerosol formulation containing a polar fluorinated molecule
MY121789A (en) Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage
DE60001492D1 (de) Pharmazeutische aerosolformulierung
DE69208660D1 (de) Fluorchlorkohlenwasserstoffreie aerosolformulierungen
JPH02200627A (ja) 医薬エアゾール製剤
MY119074A (en) Pharmaceutical aerosol composition
ATE342053T1 (de) Formulierungen zur inhalation
ATE164864T1 (de) Flüssiges kohlendioxid enthaltende treibmittel
IT1317720B1 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
CA2355651A1 (en) Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
ES2159148T3 (es) Formulaciones en aerosol de furoato de mometasona libres de clorofluorocarbonos.
WO1999024016A8 (en) Emulsions for aerosolization and drug delivery